Asset Allocation

As of June 30, 2026.
Type % Net
Cash 3.05%
Stock 64.73%
Bond 31.32%
Convertible 0.00%
Preferred 0.00%
Other 0.89%
View Asset Allocation
Start Trial

Market Capitalization

As of June 30, 2026
Large 85.97%
Mid 10.40%
Small 3.63%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 98.92%    % Emerging Markets: 0.13%    % Unidentified Markets: 0.95%

Americas 80.30%
79.76%
Canada 42.98%
United States 36.78%
0.54%
Mexico 0.06%
As of June 30, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 16.70%
United Kingdom 4.60%
11.51%
Belgium 1.12%
Denmark 0.00%
France 0.91%
Germany 2.56%
Ireland 1.31%
Italy 0.60%
Netherlands 2.20%
Switzerland 2.78%
0.00%
0.59%
Israel 0.59%
Greater Asia 2.05%
Japan 2.05%
0.00%
Australia 0.00%
0.00%
Hong Kong 0.00%
Singapore 0.00%
0.00%
Unidentified Region 0.95%

Bond Credit Quality Exposure

AAA 18.35%
AA 11.24%
A 16.06%
BBB 30.74%
BB 9.95%
B 5.28%
Below B 0.20%
    CCC 0.20%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.35%
Not Available 7.83%
Short Term 0.00%
As of June 30, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
34.04%
Materials
4.63%
Consumer Discretionary
4.17%
Financials
21.29%
Real Estate
3.95%
Sensitive
41.85%
Communication Services
3.83%
Energy
2.75%
Industrials
17.18%
Information Technology
18.08%
Defensive
21.26%
Consumer Staples
7.89%
Health Care
10.94%
Utilities
2.42%
Not Classified
2.86%
Non Classified Equity
2.86%
As of June 30, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of June 30, 2026
Type % Net
Government 11.81%
Corporate 65.22%
Securitized 0.99%
Municipal 15.48%
Other 6.49%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
1.07%
Less than 1 Year
1.07%
Intermediate
68.52%
1 to 3 Years
10.53%
3 to 5 Years
14.76%
5 to 10 Years
43.23%
Long Term
29.46%
10 to 20 Years
3.64%
20 to 30 Years
16.73%
Over 30 Years
9.10%
Other
0.94%
As of June 30, 2026
View Bond Maturity Exposure
Start Trial